Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call
October 12 2017 - 6:30AM
Business Wire
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that
financial results for the company's third quarter ended September
30, 2017 will be released on Wednesday, November 1, 2017. The
management team will host a conference call on Wednesday, November
1, 2017, at 4:30 p.m. ET to discuss the company's financial results
and recent developments. The call can be accessed by dialing
1-877-270-2148 (domestic) or 1-412-902-6510 (international) five
minutes prior to the start of the call. A passcode is not required
to access the live call from either number. A replay of the
conference call will be available until November 15, 2017 and can
be accessed by dialing 1-412-317-0088 and providing the passcode
10113366.
The live, listen-only webcast of the conference call may be
accessed by visiting the investors’ section of the company's
website at investors.foundationmedicine.com. A replay of the
webcast will be available shortly after the conclusion of the call
and will be archived on the company's website for two weeks
following the call.
About Foundation MedicineFoundation Medicine (NASDAQ:FMI)
is a molecular information company dedicated to a transformation in
cancer care in which treatment is informed by a deep understanding
of the genomic changes that contribute to each patient’s unique
cancer. The company offers a full suite of comprehensive genomic
profiling assays to identify the molecular alterations in a
patient’s cancer and match them with relevant targeted therapies,
immunotherapies and clinical trials. Foundation Medicine's
molecular information platform aims to improve day-to-day care for
patients by serving the needs of clinicians, academic researchers
and drug developers to help advance the science of molecular
medicine in cancer. For more information, please visit
http://www.FoundationMedicine.com or follow Foundation Medicine on
Twitter (@FoundationATCG).
Foundation Medicine® is a registered trademark of Foundation
Medicine, Inc.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171012005096/en/
Foundation MedicineMedia Contact:Lee-Ann Murphy,
617-245-3077pr@foundationmedicine.comorInvestor
Contact:Kimberly Brown,
617-418-2215ir@foundationmedicine.com
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Foundation Medicine, Inc. (NASDAQ:FMI)
Historical Stock Chart
From Apr 2023 to Apr 2024